Literature DB >> 30978121

The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010).

Fernand Freycon1, Léonie Casagranda1,2,3, Béatrice Trombert-Paviot3,4.   

Abstract

This study consists of a retrospective study including 71 childhood leukemia survivors (36 females) treated with allo-HSCT 12 Gy fractionated total body irradiation (fTBI) conditioning, with a median age of 25.0 y at time of follow-up and a median delay of 14.8 y since the graft. The recovery ratio was 90%. The number of severe late-effects was specified for each patient: 21 with growth deficiency (final height <162.5 cm for 12/35 men and <152.0 cm for 9/36 women - Growth deficiency was correlated to young age at the time of the allograft); 5 with sclerodermic chronic graft vs. host disease; 9 with osteonecrosis; risk of impaired fertility for 25 women and 28 men (only 2 women had a child); 8 with diabetes; 5 with pulmonary late-effects including 1 death; 5 with chronic renal insufficiency including 1 death; 2 with cardiac late-effects; 2 with arterial high blood pressure; 11 (8 women) declared 14 subsequent cancers (7 with thyroid carcinomas, 3 with multiple squamous cell carcinomas, 2 with epidermoïdis carcinomas of the tongue or the lip, 1 with bone sarcoma, and 1 with carcinoma of the breast); 6 with chelating treatments of hemochromatosis; 14 with important educational underachievement; 11 with depression at adult age; 1 with hepatitis B virus infection; 4 with other severe late-effects, including 2 with blindness. The average number of severe late-effects was 2.3 with a positive correlation according to delay from fTBI (p < 0.0002). Two-thirds had at least 2 late-effects. These results emphasize the urgent abandonment of conditioning by TBI in children.

Entities:  

Keywords:  Childhood leukemia; hematopoietic stem cell transplantation; late-effects; long-term follow-up; total body irradiation

Mesh:

Year:  2019        PMID: 30978121     DOI: 10.1080/08880018.2019.1591549

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  6 in total

1.  Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors.

Authors:  Ole Henrik Myrdal; Trond Mogens Aaløkken; Phoi Phoi Diep; Ellen Ruud; Lorentz Brinch; Kristian Fosså; Henrik Mangseth; Johny Kongerud; Liv Ingunn Sikkeland; May B Lund
Journal:  Respiration       Date:  2021-12-22       Impact factor: 3.966

2.  Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children.

Authors:  Christopher E Dandoy; Stella M Davies; Kwang Woo Ahn; Yizeng He; Anders E Kolb; John Levine; Stephanie Bo-Subait; Hisham Abdel-Azim; Neel Bhatt; Joseph Chewing; Shahinaz Gadalla; Nicholas Gloude; Robert Hayashi; Nahal R Lalefar; Jason Law; Margaret MacMillan; Tracy O'Brien; Timothy Prestidge; Akshay Sharma; Peter Shaw; Lena Winestone; Mary Eapen
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

Review 3.  Radiation-induced kidney toxicity: molecular and cellular pathogenesis.

Authors:  Richard Klaus; Maximilian Niyazi; Bärbel Lange-Sperandio
Journal:  Radiat Oncol       Date:  2021-02-25       Impact factor: 3.481

Review 4.  Pulmonary Toxicity After Total Body Irradiation - Critical Review of the Literature and Recommendations for Toxicity Reporting.

Authors:  Jennifer Vogel; Susanta Hui; Chia-Ho Hua; Kathryn Dusenbery; Premavarthy Rassiah; John Kalapurakal; Louis Constine; Natia Esiashvili
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

5.  Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen.

Authors:  A Birgitta Versluijs; Coco C H de Koning; Arjan C Lankester; Stefan Nierkens; Wouter J Kollen; Dorine Bresters; Caroline A Lindemans; Jaap Jan Boelens; Marc Bierings
Journal:  Blood Adv       Date:  2022-03-22

6.  Impacts of platinum-based chemotherapy on subsequent testicular function and fertility in boys with cancer.

Authors:  Lim Tian En; Mark F H Brougham; William Hamish B Wallace; Rod T Mitchell
Journal:  Hum Reprod Update       Date:  2020-11-01       Impact factor: 15.610

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.